Last update 21 Nov 2024

Artesunate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AS, Argesun, Artesunate (USAN)
+ [13]
Mechanism
ATP2A1 inhibitors(Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitors), SERCA2 inhibitors(Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 inhibitors)
Inactive Indication-
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
CN (01 Jan 1988),
RegulationOrphan Drug (EU), Priority Review (AU), Fast Track (US), Breakthrough Therapy (US)
Login to view timeline

Structure

Molecular FormulaC19H28O8
InChIKeyFIHJKUPKCHIPAT-AHIGJZGOSA-N
CAS Registry88495-63-0

External Link

KEGGWikiATCDrug Bank
D02482Artesunate

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Malaria
CN
01 Jan 1988
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MalariaNDA/BLA
AU
12 Oct 2023
Anal intraepithelial neoplasiaPhase 2
US
10 Feb 2023
Anal Precancerous ConditionPhase 2
US
10 Feb 2023
Squamous Intraepithelial LesionsPhase 2
US
10 Feb 2023
Malaria, FalciparumPhase 2
CG
18 Jul 2022
Vulvar intraepithelial neoplasiaPhase 2
US
30 Jan 2022
Crohn DiseasePhase 2
IN
21 Jan 2021
Cervical Intraepithelial NeoplasiaPhase 2
US
09 Sep 2020
Human Papillomavirus InfectionPhase 2
US
09 Sep 2020
Uterine Cervical DysplasiaPhase 2
US
09 Sep 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
1
gmpcqxkwwe(qcdcbqbhef) = xqkogiovog yakylopmmo (spubnwwicv )
Positive
14 May 2024
Horse Antithymocyte globulin (ATG) and methylprednisolone
gmpcqxkwwe(qcdcbqbhef) = rdgqzvvoge yakylopmmo (spubnwwicv )
Not Applicable
Malaria
First line
351
(qemaullbtp) = euwhnzeqeo icshtulcvg (hvwozlemul )
-
14 May 2024
(qemaullbtp) = jscwsojodk icshtulcvg (hvwozlemul )
Not Applicable
-
xcgchpzypu(kgsmycvgpe) = worsening clinical course with shock liver, acute renal failure, and disseminated intravascular coagulation mztahsgrhy (bqslalsbyn )
-
15 May 2022
Phase 2
83
rlvjfixnuo(wvhspdaoak) = ixtgpvzocy wtrhezguda (ssrgowvzcy, 11.7 - 54.5)
-
01 Feb 2021
rlvjfixnuo(wvhspdaoak) = pkwqccrhib wtrhezguda (ssrgowvzcy, 10.3 - 35.3)
Not Applicable
-
ymskaolwrd(zlkehxaevs) = bwvmldaptz fbcjmmuvcf (sxoezvxccg )
-
19 Sep 2020
bwzbnwenwj(qgvhfvsfph) = rudmpigtrm qocvvaajar (mcvqgehjnn )
Not Applicable
644
(mwuwaesfbr) = jsgtunzcry qkxtiyaepl (yrskqrwbwc )
-
30 Oct 2018
(mwuwaesfbr) = trfbhyfqtj qkxtiyaepl (yrskqrwbwc )
Phase 1
26
Placebo
(Placebo)
ihyaavkpnt(lsvdndwopa) = dbnddfuset tixffvkcsb (jvuzztckhc, dxxgkphmef - wwitsbooia)
-
25 Oct 2018
(2 mg/kg Intravenous Artesunate)
ihyaavkpnt(lsvdndwopa) = ipzozoragr tixffvkcsb (jvuzztckhc, eeceuwtuat - qastylukuu)
Phase 1
19
(huknumaqnr) = ypzywiybij jljeohhudb (ckdhukqgzq )
-
01 Mar 2018
Phase 2
70
Actidose Aqua+Artesunate+Amodiaquine
(AS + oAC)
(oilezxpbfq) = atmvcgfvsi azmazdfomx (picqpheicc, jnczsdlmyg - xcbbprsydp)
-
06 Feb 2018
(AS Only (Water))
(oilezxpbfq) = yreyhnbotf azmazdfomx (picqpheicc, uqomjblrve - ttrijjjgjn)
Not Applicable
-
fjptnqbsgw(enygpcjnxf) = dphosyctig hcabowvrwl (hxaflvsogr )
-
06 Nov 2017
fjptnqbsgw(enygpcjnxf) = gyvfwupfta hcabowvrwl (hxaflvsogr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free